A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jennerex Biotherapeutics
ClinicalTrials.gov Identifier:
NCT00429312
First received: January 29, 2007
Last updated: April 1, 2013
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)